Form D · Pharmaceuticals
Chondrial Therapeutics, LLC
Indianapolis, IN · CIK 0001603367
Offering snapshot reported Aug 13, 2014 · SEC filing
- Reported sold
- Yet to sell Offering amount: $1M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $500K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 13, 2014 | Initial | Yet to sell | No comparison | 1 | SEC filing |
| Jun 6, 2014 | Amendment | $100,000 | -$900,000vs Mar 28, 2014 | 1 | SEC filing |
| Mar 28, 2014 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-222790
Source: Form D, filed Aug 13, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ronald Mark Payne | Director, Executive |
| Steven Reed Plump | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
4500 East 75 Th Street
Indianapolis, IN, 46250
Indianapolis, IN, 46250